Detailed comparison on parameters like NAV | Returns | Risk | Rating | Analysis
Select a Mutual Fund
Risk | Very High | - |
Rating | - | - |
Min SIP Amount | ₹500 | - |
Expense Ratio | 2.3 | - |
NAV | ₹12.13 | - |
Fund Started | 18 Aug 2023 | - |
Fund Size | ₹160.49 Cr | - |
Exit Load | Exit Load for units in excess of 12% of the investment,1% will be charged for redemption within 90 days. | - |
Risk
Rating
Min SIP Amount
Expense Ratio
NAV
Fund Started
Fund Size
Exit Load
1 Year | 9.61% | - |
3 Year | - | - |
5 Year | - | - |
1 Year
3 Year
5 Year
Equity | 65.95% | - |
Cash | 22.70% | - |
Equity
Cash
Top 10 Holdings |
| - |
Top 10 Holdings
Name | Assets |
---|---|
Sun Pharmaceutical Industries Ltd. | 2.84% |
Trent Ltd. | 2.54% |
Bharti Airtel Ltd. | 2.52% |
Bosch Ltd. | 2.18% |
Lupin Ltd. | 2.06% |
Torrent Pharmaceuticals Ltd. | 2.05% |
Glenmark Pharmaceuticals Ltd. | 1.94% |
ICICI Bank Ltd. | 1.92% |
Persistent Systems Ltd. | 1.84% |
HCL Technologies Ltd. | 1.81% |
Name | Gargi Bhattacharyya Banerjee | - |
Start Date | 21 Nov 2019 | - |
Name
Start Date
Description | The scheme seeks to generate long term capital appreciation with inflation beating returns by investing in Equity and Equity related securities, Debt and Money Market instruments, Gold/Silver ETFs, and REITs / InvITs. There is no assurance that the investment objective of the Scheme will be achieved. | - |
Launch Date | 18 Aug 2023 | - |
Description
Launch Date